Introduction: We compare nursing-home and hospital admissions among residents with Alzheimer's disease and related dementias (ADRD) in memory-care assisted living to those in general assisted living.
Methods: Retrospective study of Medicare beneficiaries with ADRD in large (>25 bed) assisted-living communities. We compared admission to a hospital, to a nursing home, and long-term (>90 day) admission to a nursing home between the two groups, using risk differences and survival analysis.
Results: Residents in memory-care assisted living had a lower adjusted risk of hospitalization (risk difference = -1.8 percentage points [P = .014], hazard ratio = 0.93 [0.87-1.00]), a lower risk of nursing-home admission (risk difference = -2.2 percentage points [P < .001], hazard ratio = 0.87 [-.79-0.95]), and a lower risk of a long-term nursing home admission (risk difference = -1.1 percentage points [P < .001], hazard ratio = 0.71 [0.57-0.88]).
Discussion: Memory care is associated with reduced rates of nursing-home placement, particularly long-term stays, compared to general assisted living.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250544 | PMC |
| http://dx.doi.org/10.1002/alz.12513 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Utility of an Alzheimer's Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study.
Diagnostics (Basel)
January 2025
C2N Diagnostics, LLC, 4340 Duncan Avenue, St. Louis, MO 63110, USA.
: The objective of this study was to assess clinical decision-making associated with the use of a multi-analyte blood biomarker (BBM) test among patients presenting with signs or symptoms of mild cognitive impairment or dementia. : The Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey (NCT06025877) study evaluated the clinical utility of the PrecivityAD2™ blood test in a prospective, single cohort of 203 patients presenting with symptoms of Alzheimer's disease (AD) or other causes of cognitive decline across 12 memory specialists. The PrecivityAD2 blood test (C2N Diagnostics, St.
View Article and Find Full Text PDFUnderstanding urinary incontinence and urinary tract infections as key contributors to falls in assisted living and memory care communities.
Geriatr Nurs
January 2025
Chief Clinical Officer of Secure Clinical Solutions, LLC, Adjunct Lecturer of the University of Southern California (USC), Board Member of the National Association for Continence (NAFC), USA. Electronic address:
Assisted Living, Residential Care, and Memory Care Staffing Level Dynamics: Oregon, 2017-2023.
J Am Med Dir Assoc
January 2025
Institute on Aging, College of Urban and Public Affairs, Portland State University, Portland, OR, USA; Nohad A. Toulan School of Urban Studies and Planning, College of Urban and Public Affairs, Portland State University, Portland, OR, USA.
Objectives: To examine changes in staffing levels over time in Oregon assisted living and residential care (AL/RC) communities between 2017 and 2023.
Design: Longitudinal study of licensed AL/RC communities.
Setting And Participants: A total of 1720 setting-year observations from 535 individual AL/RC communities in Oregon between 2017 and 2023.
Staffing Patterns in Nursing Homes, Assisted Living Communities, and Memory Care Units: Variation Across Shifts.
J Am Med Dir Assoc
November 2024
Scripps Gerontology Center, Miami University, Oxford, OH, USA.
Objectives: To assess the staffing patterns of direct care nursing staff by shift in nursing homes (NHs), assisted living communities (ALCs), and their corresponding memory care units (MCUs).
Design: Observational study of the 2021 Ohio Biennial Survey of Long-Term Care Facilities and the Payroll-Based Journal data for December 2021.
Setting And Participants: NHs (n = 678) and ALCs (n = 542) that reported staffing by shift in Ohio.
Data-driven retrieval of population-level EEG features and their role in neurodegenerative diseases.
Brain Commun
July 2024
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Article Synopsis
- Electrophysiologic changes in neurodegenerative disorders like Alzheimer's and Lewy Body disease can be identified using EEG, providing insight into disease severity.
- Traditional EEG analysis is limited by biases from preset feature selection; this study uses a data-driven tensor decomposition method to extract key EEG activity features during resting states.
- By analyzing data from over 11,000 patients, the researchers developed an algorithm to differentiate cognitive impairment and dementia types based on identifiable EEG patterns, which showed correlations with mental status and biomarkers.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!